Researchers have identified an antioxidant in locally grown black tea leaves as a potential inhibitor of protease activity in SARS-CoV-2, the virus that causes COVID-19, Chiayi Chang Gung Memorial Hospital said on Wednesday.
A research team led by Wu Ching-yuan (吳清源), head of the hospital’s Department of Traditional Chinese Medicine, used a computer program to identify potential antiviral components in traditional plants, the hospital said in a statement.
Theaflavin, a polyphenolic compound, shows broad-spectrum antiviral activity against several viruses and could be used as a lead compound for the development of a SARS-CoV-2 inhibitor to target the DNA-directed ribonucleic acid (RNA) polymerase (RdRp) enzyme.
Photo copied by Lin I-chang, Taipei Times
In coronaviruses, RdRp catalyzes the replication of RNA from a template, making it an attractive candidate to help develop a treatment, Wu said.
RdRp in SARS-CoV-2 is also a primary target for the antiviral remdesivir, which the WHO has called the most promising drug available for the treatment of COVID-19, he said.
Remdesivir works by inhibiting RdRp, which many RNA viruses — including coronaviruses — use to replicate themselves.
The antiviral effects of theaflavin are similar to those of remdesivir, Wu said.
However, the exact in vivo effect is still unclear, and further research is needed to confirm the mechanism whereby theaflavin targets SARS-CoV-2, Wu said.
The findings were published by the American Society for Microbiology in the Journal of Medical Virology on March 13, the hospital said.
In other news, the Central Epidemic Command Center (CECC) on Thursday said that quinoline antimalarial drugs, which have been discussed as a possible treatment for COVID-19, are produced in Taiwan and could be made available if testing proves them to be effective against the novel coronavirus.
In a small French study, doctors used a drug in the quinoline family — hydroxychloroquine — to reduce the duration and severity of COVID-19 symptoms in people with mild cases, said Chang Shan-chwen (張上淳), convener of the center’s expert advisory panel.
If properly tested and approved, a process that normally takes 12 to 18 months, the drug could conceivably reduce the burden on medical resources such as quarantine facilities, Chang said.
Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the CECC, said that there is one manufacturer of quinoline drugs in Taiwan.
If the treatment were proved to be viable, the government’s first priority would be to guarantee domestic supply, Chen said.
The government could participate in the distribution of the drug on the precondition of not harming the manufacturer’s commercial interests, Chen said.
Internationally, drug distribution rights could be used diplomatically to build ties with international partners to address shortages amid the pandemic, he said.
Drugs that have been touted as potentially effective against COVID-19 have become the subject of heated competition in the past few weeks as governments scramble to combat the disease.
Remdesivir is being used on a trial basis in Taiwan and has reduced fevers in the three COVID-19 patients who have been treated with it, although its effect on overall recovery time is still being studied, Chang said.
A domestically developed “suicide drone,” also known as a loitering munition, would be tested and evaluated in July, and could enter mass production next year, Taiwan’s weapons developer said on Wednesday. The yet-to-be-named drone was among nine drone models unveiled by the National Chungshan Institute of Science and Technology (NCSIST) on Tuesday. The drone has been dubbed the “Taiwanese switchblade” by Chinese-language media, due to its similarity to the US-made AeroVironment Switchblade 300, which has been used by Ukraine in counterattacks during Russia’s invasion. It has a range of more than 10km, a flight time of more than 15 minutes, and an electro-optical
GOOD INFLUENCE: Kwan said his mother tutored him at home for a few years, saying that she had to protect his ‘creativity’ as his writing had suffered Director and coproducer of the Oscar-winning absurdist comedy-drama Everything Everywhere All at Once Daniel Kwan (關家永) on Sunday dedicated the movie to his Taiwanese mother, who he said supported his creativity growing up. “She is someone who sacrificed a lot for her kids,” Kwan, 35, said backstage at the Oscars. The movie, released early last year, received a commanding 11 nominations at the Academy Awards, and won seven, including Best Picture, Best Director, Best Actress, Best Supporting Actor, Best Supporting Actress, Best Original Screenplay and Best Film Editing. Kwan and Daniel Scheinert, with whom he also directed the 2016 fantasy film Swiss Army
A bipartisan US congressional delegation arrived in Taiwan yesterday on a two-day visit that is to include meetings with President Tsai Ing-wen (蔡英文) and other senior government officials, the Ministry of Foreign Affairs said. The delegation comprises Republican US representatives and Chairman of the Defense Appropriations Subcommittee Ken Calvert, Tom Cole, Dave Joyce and Mike Garcia, as well as Democratic US Representative Ed Case, the ministry said in a news release. Upon their arrival at Taipei International Airport (Songshan airport), the five representatives were welcomed by North American Affairs Department Director-General Douglas Hsu (徐佑典), it said. During their visit, they are to meet
The Taipei City Government on Wednesday introduced of a series of tourism promotions, including free sightseeing bus tours and hotel discounts, in a bid to boost the number of international visitors. From now until June 30, 10,000 free Taipei Sightseeing Bus tickets are to be made available to travelers who stay in designated hotels for two nights, cruise passengers and European visitors transiting for more than 15 hours, the Taipei Department of Information and Tourism said. Eligible tourists can ask for the free four-hour unlimited ride bus tickets by presenting their passports at the hotels they stay in or from the
RSS